Schedule 13G ownership disclosure
MEDIWOUND LTD
COMMON STOCK · CUSIP: M68830112
Event date: 2025-12-31
- Filing-level shares
- 554,498
- Percent of class
- 4.3%
- T. Rowe Price Associates, Inc.
Shares: 554,498 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-26-000264
- Form type
- SCHEDULE 13G/A
- Filer
- MediWound Ltd.
- CIK
- CIK 1593984
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership